Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E-2 release

Tools
- Tools
+ Tools

UNSPECIFIED. (2004) Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E-2 release. EUROPEAN JOURNAL OF BIOCHEMISTRY, 271 (20). pp. 4042-4052. ISSN 0014-2956

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1111/j.1432-1033.2004.04342.x

Abstract

In A549 pulmonary cells, the dexamethasone- and budesonide-dependent repression of interleukin-1beta-induced prostaglandin E-2 release was mimicked by the steroid antagonist, RU486. Conversely, whereas dexamethasone and budesonide were highly effective inhibitors of interleukin-1beta-induced cyclooxygenase (COX)/prostaglandin E synthase (PGES) activity and COX-2 expression, RU486 (< 1 mum) was a poor inhibitor, but was able to efficiently antagonize the effects of dexamethasone and budesonide. In addition, both dexamethasone and RU486 repressed [H-3]arachidonate release, which is consistent with an effect at the level of phospholipase A(2) activity. By contrast, glucocorticoid response element-dependent transcription was unaffected by RU486 but induced by dexamethasone and budesonide, whilst dexamethasone- and budesonide-dependent repression of nuclear factor-kappaB-dependent transcription was maximally 30-40% and RU486 (< 1 mum) was without significant effect. Thus, two pharmacologically distinct mechanisms of glucocorticoid-dependent repression of prostaglandin E-2 release are revealed. First, glucocorticoid-dependent repression of arachidonic acid is mimicked by RU486 and, second, repression of COX/PGES is antagonized by RU486. Finally, whilst all compounds induced glucocorticoid receptor translocation, no role for glucocorticoid response element-dependent transcription is supported in these inhibitory processes and only a limited role for glucocorticoid-dependent inhibition of nuclear factor-kappaB in the repression of COX-2 is indicated.

Item Type: Journal Article
Subjects: Q Science > QD Chemistry
Journal or Publication Title: EUROPEAN JOURNAL OF BIOCHEMISTRY
Publisher: BLACKWELL PUBLISHING LTD
ISSN: 0014-2956
Date: October 2004
Volume: 271
Number: 20
Number of Pages: 11
Page Range: pp. 4042-4052
Identification Number: 10.1111/j.1432-1033.2004.04342.x
Publication Status: Published
URI: http://wrap.warwick.ac.uk/id/eprint/7935

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us